Introduction
Apoptosis is a self destruction event leading to the elimination of unwanted cells from multicellular organisms. In developing embryo, apoptosis plays a key role in tissue morphogenesis. In adults it participates in tissue homeostasis. Deregulation of apoptosis leads to degenerative disorders or cancers (Thompson, 1995) . During the last decade, the basic molecular mechanisms of apoptosis have been elucidated. In particular, it has been established that in most cases, apoptosis is due to irreversible activation of a cascade of particular cysteine proteases (caspases) which cleave their targets at the level of aspartate residues (Henkart, 1996) . A central event, which leads to caspase activation is the release of cytochrome c from mitochondria into the cytoplasm (Kroemer et al., 1997) . Although the exact mechanisms monitoring cytochrome c subcellular localization are still partly unknown, a number of reports support the notion that a decrease in the mitochondrial transmembrane potential (Dc M ) observed in early steps of the apoptotic response is responsible for the release of cytochrome c into the cytoplasm (Kroemer et al., 1997; Zhivotovsky et al., 1998; Martinou, 1999) . The Bcl-2 family of inhibitors of apoptosis may act by stabilizing cytochrome c interactions with the inner mitochondrial membrane thus preventing the activation of caspases (Kluck et al., 1997; Rosse et al., 1998) . These proteins show four homology domains (BH1-4) forming ahelices (Kelekar and Thompson, 1998) . BH1 and BH2 domains exhibit the highest degree of conservation throughout the family. All inhibitors of apoptosis possess the four BH domains. In contrast a number of apoptosis accelerators lack the BH4 domain, a subgroup of apoptosis accelerators even possessing only the BH3 domain. These proteins can interact with the outer mitochondrial membrane via their hydrophobic C-terminal region (Nguyen et al., 1993; Krajewski et al., 1993; Yang et al., 1995) . In addition, structural data have revealed that they may share functional properties with pore-forming bacterial colicins (Muchmore et al., 1996) . Indeed, although in conditions which seem far from physiological situations, Bcl-2 can form pores in arti®cial membranes (Schlesinger et al., 1997; Minn et al., 1997) . The pore forming domain has been identi®ed and corresponds to two amphipatic helices, which are conserved among the Bcl-2 family (Matsuyama et al., 1998) . In addition to their ability to interact with the bilayer, Bcl-2 proteins participate in a network of interactions between cellular proteins, which may or may not belong to the Bcl-2 family. For example Bcl-2 can interact with Bax, a Bcl-2 homologue having pro-apoptotic properties and with the mitochondrial proteins VDAC-voltage-dependent anion channel-and ANT-adenosine nucleotide translocator- (Otter et al., 1998; Shimizu et al., 1999; Brenner et al., 2000) . In addition to mitochondrial proteins, Bcl-2 interacts with numerous partners such as calcineurin (Shibasaki et al., 1997) , the kinase Raf-1 and the transcriptional repressor Btf (Kasof et al., 1999) . However, the exact nature of these interactions remain unclear. Nevertheless, the combination of the above data suggest together that Bcl-2 proteins are at the cross road between mitochondria and cell signalling pathways, which directly or indirectly participate in the control of cell survival.
The anti-and pro-apoptotic members of the Bcl-2 family are respectively potential oncogenes and tumour suppressors. Indeed, a number of cancer cells express inhibitors of cell death or down regulate expression of apoptosis accelerators (Reed et al., 1988; Li and Dou, 2000) . Tumors overexpressing inhibitors of apoptosis of the Bcl-2 family often exhibit strong resistance to anticancer drugs (Walczak et al., 2000; Yang et al., 2000) . Actually these proteins are key actors in oncogenesis and resistance to chemotherapy. In this context, identi®cation of new Bcl-2-related sequences is thus essential for a detailed understanding of apoptosis control and can be of considerable therapeutic interest for humans. We describe, here, the molecular cloning and characterization of a new inhibitor of apoptosis in humans. This protein (Nrh, for Nr-13 human), which possesses the four Bcl-2 homology domains BH1-4, is the closest human homologue of the avian protein Nr-13, involved in tumour formation following infection by the Rous sarcoma virus (Gillet et al., 1993 (Gillet et al., , 1995 Mangeney et al., 1996) . Moreover, we show that Nrh interacts strongly with Bcl-Xs and counteracts its death-inducing eect. Finally, detection of Nrh both at the level of mitochondria and nuclear membrane, suggests that it may participate both in the control of mitochondria activity and of nucleocytoplasmic traf®cking.
Results
Molecular cloning and characterization of Nrh, a human homologue of avian Nr-13 and murine Diva/Boo
Computer-assisted screening of public human EST databases led to the selection of clone #AA005293. This clone has a partial open reading frame potentially corresponding to a product having signi®cant homologies with the avian anti-apoptotic protein Nr-13 and the mouse protein Diva/Boo. Comparison with the human genome sequence available at NCBI indicated the entire ORF actually encodes a new Bcl-2 family member of 194 amino acids exhibiting the typical homology domains BH1 ± 4 and C-terminal transmembrane domain predicted by hydrophobicity pro®le analysis. The organization of this new gene shows one single intron which splits the ORF within the BH2 region, i.e. at a location which is conserved among anti-apoptotic members of the bcl-2 family (Figure 1 ). The genomic organization of chicken Nr-13 and mouse Diva/Boo has been determined (our unpublished results). Comparison with Nrh shows that these three genes share the same organization with one single intron located at the same position. In silico screening of the human genome revealed that Nrh is a single copy gene located on chromosome 15 (locus 15q21), in the vicinity of several Mittelman breakpoints, according to the NCBI database.
Since the EST clone lacked part of the ORF, a human genomic library was screened to obtain a genomic clone containing the missing sequence. One clone containing the entire 1st exon has been isolated. Nrh ORF was then reconstructed using a PCR-based strategy and the EST and genomic clones as templates. Figure 1 Genomic organization of nrh. Open reading frame and anking sequences of nrh. Two potential in frame ATG initiator codons are shown in bold characters. The presence of an inverted repeat allows the formation of a hairpin loop (shaded), suggesting that the downstream ATG is the main initiator codon. The deduced aminoacid sequence starting at the second ATG is shown below the nucleotidic sequence (block letters, one letter code). Position of the intron with splice donor and splice acceptor sites is indicated (italics). The polyadenylation site (boxed) and the polyA tail are shown. Below the genomic sequence a diagram summarizes the overall organization of nrh, showing the intron and the conserved functional domains of the protein encoded by the two exons, together with the conserved a1 ± a7 helices present in inhibitors of apoptosis Oncogene A human homologue of the anti-apoptotic protein Nr-13 A Aouacheria et al Expression of nrh transcript was determined by PCR carried out on commercially available cDNAs obtained from human tissues. Figure 2 shows that nrh is preferentially expressed in adults in the lungs, the liver, and the kidneys.
Multiple alignments (Clustal W software) of the various Bcl-2 family members clearly show that Nrh has the highest homology with avian Nr-13 among the human Bcl-2-like sequences (25% identical residues and 28% similar residues, i.e. 53% total homology). This homology is particularly high in the BH1 region with a 14 aminoacid-long conserved motif-residues #84 ± 97 in Nrh-and in the BH2 region which exhibits a 11 amino acid-long conserved motif ± residues #150 ± 160 in Nrh- (Figure 3a) . Among the other vertebrate sequences, Nrh shares also a high homology with the murine protein Diva-Boo (80% total homology), whereas Nr-13 and Diva/Boo share 58% total homology. Indeed a phylogenic tree constructed on the basis of the Clustal W multiple alignment indicates that these three proteins belong to the same subgroup within the Bcl-2 family (Figure 3b ). Thus, Nrh, Diva/ Boo and Nr-13 derive from a common ancestor.
Nrh is an inhibitor of apoptosis
In order to study the eect of Nrh on cell survival, the corresponding ORF was subcloned in yeast and vertebrate expression vectors. Careful analysis of the nrh transcript sequence showed two in frame ATG codons, both of which being¯anked by a Kozak consensus sequence. The presence of an inverted repeat (5'-CCCGCTGCGGG) allowing the formation of a hairpin loop ®ve nucleotides downstream of the second ATG suggested that this ATG may be preferentially used as an initiator codon (Kozak, 1990) . Moreover, sequence alignment with Diva/Boo and Nr-13 in their N-terminal regions show a closer homology with the shorter Nrh protein (Figure 3 ). Actually the additional 10 amino acid-long sequence potentially driven by the upstream ATG has no homology with Diva/Boo or Nr-13. The ORF beginning with the downstream ATG was therefore subcloned in yeast (pGILDA, pJG4-5) and vertebrate (pSG-5-FLAG) expression vectors for functional analysis. (Inohara et al., 1998; Song et al., 1999) , chicken Nr-13 (Gillet et al., 1995) and herpesvirus HVT096 (Afonso et al., 2001) . Identical amino acids are boxed in black, similar aminoacids are shaded (dark grey: strong similarity; light grey: weak similarity). Consensus line: identities`*'; strong similarities`:'; weak similaritỳ .'. Position of BH1, BH2, BH3 and BH4 domains together with the position of the predicted C-terminal transmembrane domain (TM) are shown. (b) Phylogenetic tree of Bcl-2 family based on 94 reliably aligned homologous sites computed with the NeighbourJoining method applied to PAM evolutionary distances and rooted with the nematode sequence. Horizontal lengths (see scale) represent evolutionary distances. Numbers represent bootstrap scores, in per cent out of 500 replicates, and measure the reliability of sequence clusters at right. The tree suggests Human Nrh, Mouse Diva/Boo, Quail NR13 and Zebra NR to be orthologous genes and reveals that the two mammalian genes have evolved much faster than other members of the family
The eect of Nrh on cell survival has ®rst been studied in yeast, commonly used as a`test tube' for the study of the basic mechanisms of apoptosis. As shown in Figure 4 , overexpression of Nrh using the pJG4-5 yeast expression vector has no inhibitory eect on cell growth, suggesting that, contrary to Bax, Nrh is not pro-apoptotic. Moreover, Nrh prevents Bax-induced cell death although less eciently than the chicken protein Nr-13. Together, these results suggest that Nrh is an inhibitor of apoptosis.
Nrh eect on cell survival was also studied in vertebrate cells. To this end, Nrh cDNA was cloned downstream of SV40 promoter of the pSG5 expression vector and transiently expressed in Cos-7 cell line. In these experiments, Nrh protein was tagged with the FLAG epitope at its N-terminal end. As shown in Figure 5 , serum withdrawal induced cell death in Cos-7 cells as shown by phosphatidyl serine exposure and propidium iodide labelling. We show here that, upon serum withdrawal, cell death is increased by the apoptosis accelerator Bad, whereas it is prevented by Bcl-2. Similarly, Bid increases apoptosis, whereas Bcl-W prevents serum-induced apoptosis (not shown). Interestingly, in these experiments Nrh has a clear antiapoptotic eect, which is comparable to Bcl-2 and Bcl-W. Thus Nrh behaves as an inhibitor of apoptosis both in yeast and vertebrate cells.
Nrh associates with Bcl-Xs and counteracts its death-inducing effect
One characteristic of Bcl-2-related regulators of apoptosis is the formation of homo-or heterodimers, which have antagonistic properties. Apoptosis is controlled by the combined action of these dierent protein complexes. We have used a double hybrid screen to analyse some of the binding capacities of Nrh. As shown in Figure 6 , Nrh forms homodimers and can very eciently heterodimerize with Bcl-Xs, as illustrated by the strong X-Gal coloration. Nrh also appears to bind to Bcl-2, although with lower anity as shown by the light blue coloration. In these experiments X-gal staining is detected rapidly (48 h incubation at 308C). A blue staining due to low b-gal activity could be observed in yeast cells coexpressing Bax and Nrh, when incubation is extended for 24 ± 48 h (not shown). This observation indicates that Nrh can actually bind to Bax although with low anity. In contrast, no association could be detected between Nrh and the apoptosis inhibitor Bcl-Xl, even after an extended period of incubation.
The fact that Nrh exhibits a high anity for Bcl-Xs suggested that it may inhibit apoptosis by counteracting Bcl-Xs death-inducing eect. To test this hypothesis, the eects of Bcl-Xs and Nrh expressed either alone or in combination were analysed in Cos-7 cells. In these experiments cell death was estimated by determination of the percentage of pycnotic nuclei on the subpopulation of transfected cells expressing the proteins of interest (Nrh, Bcl-2, Bcl-xS). Expression of these proteins was detected by immunocytochemistry (see Materials and methods for details). The results reported in Figure 7 clearly show that ectopic expression of Bcl-Xs alone accelerates cell death in Cos-7 cells (upper panel, compare lanes empty vector, Bcl-Xs and Nrh) whereas Nrh alone has no such eect. In contrast, Nrh can totally reverse the death eect of Bcl-Xs (Figure 7 , compare lanes Bcl-Xs and Bcl-Xs+Nrh), being more ecient than Bcl-2 itself ( Figure 7 , compare Bcl-Xs, Bcl-Xs+Nrh and BclXs+Bcl-2). Therefore Nrh behaves as a potent Bcl-Xs antagonist. Similar results were obtained using another cell viability test (Trypan blue exclusion, not shown).
Nrh colocalizes with mitochondria and the nuclear membrane
Bcl-2-related proteins are associated with the outer mitochondrial membrane, where they may monitor the interaction of cytochrome c with the inner mitochondrial membrane by imperfectly elucidated mechanisms. Whereas Bcl-Xl is permanently associated with the mitochondria, Bax, which is normally sequestrated in the cytosol, is directed towards the outer mitochondrial membrane following an apoptotic stimulus. The subcellular localization of Nrh was examined by immunocytochemistry. As shown in Figure 8a , in Cos-7 cells transfected by expression vector pSG5-FLAG-Nrh, Nrh protein partly colocalizes with mitotracker TM labelling and the mitochondrial protein Bcl-Xs, suggesting that Nrh is a mitochondrial protein.
For comparison, the pattern obtained with Bcl-2 is shown. Interestingly it can be observed that the antiFlag antibody used to detect Nrh labels not only the mitochondrial compartment but also draws a ring shaped halo at the periphery of the nucleus, which is not observable with Mitotracker (Figure 8a ). This observation prompted us to check for a perinuclear envelope localization for Nrh. Figure 8b shows that, at higher magni®cation, Nrh exhibits the same distribution as nucleoporin a component of the nuclear pore complex. 
Discussion
In this study we describe the cloning and characterization of a new gene (nrh, for nr-13 human) encoding a human homologue of the anti-apoptotic protein Nr-13. This gene has been discovered by comparing the mouse Diva/Boo sequence and the chicken Nr-13 sequence with the human EST database available at NCBI using the TBLASTN search. Nrh is the closest homologue of Nr-13 known to date in humans. Nrh protein exhibits the four Bcl-2 homology domains (BH1 ± 4) and a transmembrane domain typical of anti-apoptotic proteins of the Bcl-2 family. Among the Bcl-2 family, Nrh belongs to a subgroup involving the avian sequences Nr-13 (Gillet et al., 1995) and HVT096
(from turkey herpes virus, see Afonso et al., 2001 ) and the mouse sequence Diva/ Boo (Inohara et al., 1998; Song et al., 1999) . Thus these proteins come from a common ancestor. Moreover, the fact that these three genes exhibit an identical intron/exon organization, supports the idea that they are indeed true orthologues. Interestingly, avian and human Bcl-2 sequences are very close (87% total homology) compared to Nrh and Nr-13 (53% total homology). Similarly, Nrh and Diva/ Boo share 80% total homology, to be compared to the high degree of homology between Human and Mouse Bcl-2 (94% total homology). Together CLUSTAL multiple alignments and deduced phylogenic tree suggests that Human Nrh, Mouse Diva/Boo, Quail NR13 and Zebra NR to be orthologous genes and Transient transfections in Cos-7 cells using pSG5 or pSFFV-neo expression vectors containing SV40 promoter. Cells at 50% con¯uence were transfected either by empty vectors or by recombinant vectors expressing Bad (pSFFV-HA-BAD), Bcl-2 (pSFFV-BCL-2) or Nrh (pSG5-FLAG-NRH). Cells were grown for 48 h with serum (+) or not (7). Apoptosis detection was performed on oating cells mixed to trypsinized adherent cells. Detection of cell death by FACS, using Annexin V FITC (top panels) or Propidium iodide (middle panels). Numbers represent percentage of Propidium iodide positive cells (dying cells) or Annexin V (apoptotic cells). Removal of serum induces cell death in Cos cells transfected by empty vector pSG5 (the same result is obtained with empty pSFFV, not shown here). Bad accelerates this eect, whereas Bcl-2 and Nrh prevent cell death with the same ecacy. Bottom panels: control of protein expression by immunocytochemistry using anti-FLAG or anti-HA antibodies. The secondary antibody is labelled by Alexa TM green (488 nm)¯uorochrome. Nuclei are labelled using Hoechst¯uorochrome. Estimation of transfection ecacy was 30 ± 40% for Bcl-2 and Nrh, and 5 ± 10% for Bad. A lower fraction of live cells actually express Bad, compared to Bcl-2 or Nrh, due to the powerful death-inducing eect of this protein reveal that the two mammalian genes have evolved much faster than other members of the family.
Analysis of Nrh nucleotide sequence has revealed two possible ATG initiator codons both of which arē anked by Kozak consensus sequences (Kozak, 1987) . The downstream codon governs the synthesis of a protein with homology with Nr-13 throughout the whole BH4 domain, in contrast use of the upstream codon leads to a product with an additional sequence of 10 amino acids with no homology with Nr-13. Actually, an inverted repeat allowing formation of a hairpin loop 5 nucleotides 3' of the downstream ATG strongly suggests it is preferentially used as the initiator codon. Indeed such secondary structures greatly favour recognition of initiator codons by the translation machinery (Kozak, 1990) . In vitro translation experiments have shown that this codon is actually functional (not shown). Although use of the upstream ATG cannot be entirely ruled out, we have selected in this study the downstream ATG as the main initiator codon. Interestingly, a third in frame ATG located 210 nucleotides downstream of the main initiator codon potentially leads to the synthesis of a truncated protein lacking BH1 and BH2; an ATG codon at the same position exists in Diva/Boo, but not in Nr-13. Thus, this raises the possibility that various isoforms of Nrh and Diva/Boo, having potentially antagonistic eects, can be synthetized due to the presence of these dierent initiator codons. The fact that Diva/Boo has been reported as an inhibitor (Song et al., 1999) or an accelerator (Inohara et al., 1998) of apoptosis might be due to the usage of dierent ATG codons, depending on the cell type. The same situation may exist for Nrh. Therefore, in addition to isoforms due to alternative splicing events as described for a number of Bcl-2 members (Eguchi et al., 1992; Boise et al., 1993; Zhou ., n=3) . Bcl-Xs death-inducing eect is prevented by Nrh and to a lesser extend by Bcl-2. Below: estimation of the ecacy of transfection by immunocytochemistry using anti-FLAG for Nrh and anti-HA for Bcl-Xs and a speci®c monoclonal antibody for Bcl-2. In all the experiments the secondary antibody is coupled to Alexa. Every slide is counterstained with Hoechst uorochrome to show nuclei. As already shown for Bad (see Figure 5 ), fewer cells express Bcl-Xs, compared to Bcl-2 or Nrh, due to its potent death eect. Empty vector corresponds to pSG5, the results obtained with empty pSFFV are identical and are not shown here Oncogene A human homologue of the anti-apoptotic protein Nr-13 A Aouacheria et al Hsu and Hsueh, 1998) various Nrh isoforms may be generated by the utilization of dierent ATG initiator codons.
RT ± PCR experiments performed on RNAs from adult tissues allowed us to detect Nrh transcript in lung, liver, and kidney. Actually, Nrh transcript was undetectable by Northern blot in these tissues, indicating that this gene is expressed at a low level in adult tissues (not shown). Obviously it cannot be ruled out that a high expression of Nrh takes place in other tissues, which have not been tested in this study. In particular, further analysis of Nrh expression in embryonic tissues would be necessary to check if, like other inhibitors of apoptosis, nrh expression is developmentally regulated.
The eect of Nrh on cell survival was tested in yeast and vertebrate Cos-7 cells. Actually, Nrh prevents Baxinduced growth arrest in yeast and inhibits apoptosis due to serum removal in Cos-7 cells. The anti-Bax eect in yeast is less pronounced than Nr-13, suggesting that Bax may not be the genuine partner of Nrh, contrary to Nr-13, which binds to Bax very eciently (unpublished results). In Cos-7 cells Nrh inhibits apoptosis with the same ecacy, compared to Bcl-2 ( Figure 5 ) and Bcl-W (not shown). Taken together these results establish the anti-apoptotic function of Nrh.
To further study the binding properties of Nrh, we have carried out a double hybrid screen using Nrh as bait against a number of Bcl-2 family members. These experiments have shown that Nrh can form homodimers and associates with Bcl-Xs with a high anity but does not associate with the apoptosis inhibitor BclXl. Surprisingly, Bax/Bcl-2 interactions were not detected in these experiments. In such double hybrid screen, lack of interaction may be due to conformation of the fusion proteins, which could hide dimerization domains. The same phenomenon has been reported earlier with Bcl-xL or Al (Simonen et al., 1997; Zhang et al., 2000) . Association between Nrh and Bax was actually detected after an extended incubation period to enhance X-Gal blue staining. This con®rmed the low anity of the binding between Bax and Nrh (in these conditions, Bcl-Xl remained negative, assessing the speci®city of the staining). In contrast, a very strong interaction was observed with Bcl-Xs, another apoptosis accelerator, suggesting that Nrh could counteract Bcl-Xs death inducing eect. This was con®rmed in Cos-7 cells where Nrh was found to totally reverse the death promoting eect of Bcl-Xs. The anti-Bcl-Xs eect of Nrh could not be tested in yeast since Bcl-Xs is non toxic in yeast (not shown, see also Tao et al., 1997) . Together these results suggest that, at least in part, Nrh inhibits apoptosis via its association with the apoptosis accelerator Bcl-Xs. Interestingly, interaction matrix revealed a weak interaction between Nrh and Bcl-2, suggesting that in some circumstances Nrh may inhibit the eect of Bcl-2, and thus behave as an apoptosis accelerator. Alternatively, Nrh may promote a pro-apoptotic eect of Bcl-2. Indeed, Diva/Boo, which is the mouse orthologue of Nrh has been described as death inducer or death inhibitor, depending on cell type (Inohara et al., 1998; Song et al., 1999 ). However it is equally possible that Nrh has no eect on Bcl-2 function.
Bcl-2 family members are associated with the outer mitochondrial membrane either transiently or permanently, depending on the extracellular environment (Nguyen et al., 1993; Goping et al., 1998; Nouraini et al., 2000; Wolter et al., 1997; Eskes et al., 2000) . Some of them have been detected in other intracellular membranes, mainly in the endoplasmic reticulum, suggesting that they have some mitochondria-independent functions (Krajewski et al., 1993; Janiak et al., 1994; Hoetelmans et al., 2000) . We have analysed Nrh subcellular localization in Cos-7 cells transfected with pSG5-FLAG-Nrh by immunocytochemistry. We have shown that Nrh colocalizes with mitotracker and BclXs in the mitochondrial compartment. However Nrh Figure 8 Subcellular localization of Nrh. Fluorescence microscopy. Cos-7 were transfected by pSG5FLAG-Nrh, pSFFV-Bcl-2 or pSSV-HA-Bcl-Xs. Immunostaining was performed 24 h after transfection using Alexa TM green-labelled secondary antibodies. Before ®xation, Mitochondria are stained using Mitotracker TM Red CMXRos. Cells are ®xed, nuclei and nuclear membrane are respectively stained with Hoechst¯uorochrome and a monoclonal antibody raised against nucleoporin. Nrh colocalizes with mitochondria (top panels`anti-Flag-Nrh') and with nucleoporin (compare bottom panels`anti-Flag Nrh' and`anti-nucleoporin'). For comparison, localization of Bcl-Xs and Bcl-2 proteins is shown (top panels). Bcl-Xs exhibits a strict mitochondrial localization, while Bcl-2 staining colocalizes with mitotracker and other intracellular membranes (including the periphery of the nucleus) was also detected at the level of the nuclear membrane where it colocalizes with nucleoporin. The fact that Nrh is associated with the nuclear membrane may re¯ect a direct role of Nrh at the nuclear level, like the control nuclear membrane tracking and/or gene expression. Analysis of the precise functions of Nrh in normal or tumour human cells is currently under investigation.
Materials and methods

Cloning and characterization of NrH
Human EST clone # # AA005293 was selected by tBLASTN search using Nr-13 and Diva/Boo sequences as queries. This clone was obtained from UK HGMP Resource Center, Cambridge. Sequencing of this clone revealed that it lacked part of the ORF at its 5' end. The insert was excised by EcoRI/PacI and used as a probe to screen a human genomic library (Clontech) following standard protocols (Sambrook et al., 1989; Espanel et al., 1998) . One clone containing the lacking sequence was selected. The whole ORF was reconstructed by PCR using the EST and genomic inserts as templates. Before PCR reaction, genomic and EST sequences were digested by BstEII and HinfI respectively. The two inserts were then mixed with upstream oligo #1 (TTAACTCGAGCCGACCCGCTGC), containing an XhoI site (underlined), and downstream oligo #2 (GCTGCTCAC-TAGTTCATAATAATCGTG), containing a SpeI site (underlined). Oligo #1 hybridizes with the sequence corresponding to codons #2 ± 5, relative to the downstream ATG shown in Figure 1 . Oligo #2 hybridizes with a 14 nucleotide-long region containing the stop codon, (see Figure 1) . After PCR ampli®cation, the PCR product was cloned in PGEMT vector (Promega) and subsequently subcloned into XhoI and SpeI unique sites of pSG5-FLAG to give pSG5-FLAG-NrH, expressing NrH protein tagged with the FLAG epitope (Kodak) at its C-terminal end. Constructions were veri®ed by sequencing of both DNA strands.
Nrh transcript was detected by PCR using commercially available cDNAs (Clontech). PCR reactions were carried out following manufacturer's instructions.
Multiple alignment and phylogenetic analyses
Nrh sequence was automatically aligned with other Bcl-2 proteins using CLUSTAL W. The deduced phylogenic tree was obtained using the Neighbour-Joining method applied to PAM evolutionary distances and rooted with the nematode sequence Ced-9. Computer analyses were carried out using the PBIL facilities (PoÃ le Bioinformatique Lyonnais at UniversiteÂ Claude Bernard. http://pbil.univ-lyon1.fr).
Yeast growth assays
Yeast expression vectors used in this study are described in Golemis and Khazak, 1997 . For yeast growth analyses Nrh and Nr-13 ORFs were cloned into the EcoRI/XhoI sites of pJG4-5 using PCR-based strategies. All constructs were con®rmed by DNA sequencing. pGILDA-Bax was obtained after RcCMV-Bax (a gift from S Korsmeyer) PCR-ampli®-cation using 5'-ATATGAATTCATGGACGGGTCCGG-GGAGCAG-3' (EcoRI site underlined) and 5'-ATAT-CTCGAGTCAGCCCATCTTCTTCCAG-3' (XhoI site underlined) oligonucleotides as primers. The ampli®ed product was digested with EcoRI and XhoI and ligated into EcoRI/ XhoI-cut pGILDA. The same strategy was used for Nrh subcloning, using the following upstream and downstream primers respectively: 5'-ATATGAATTCGCCGACCCGCT-3' and 5'-ATGTCTCGAGTCAATAATAATCGT-3' EGY40 strain was co-transformed with pGILDA-Bax and pJG4-5 encoding Nr-13 or Nrh. Selective media containing 2% glucose was inoculated with a single colony of transformants and incubated overnight at 308C. Subsequently, cells were washed three times with H 2 O. Typically, 10 ml of selective medium with 2% galactose was inoculated at OD600 nm=0.1. Growth was monitored for 48 h. Samples were taken at dierent time points, and cell density was measured by determining the OD at 600 nm. When necessary, appropriate dilutions were performed to maintain cells in exponential growing phase.
Two hybrid assay
Interaction mating assays were performed mainly as described (Golemis et al., 1999) , using EGY48 and EGY42 strains. EGY42 was co-transformed with pSH18-34 containing lacZ reporter gene pGILDA containing Bid, Bcl-W, Bax or Nrh as baits while EGY48 was transformed with pJG4-5 expressing Nrh, Bax, Bcl-2, Bcl-Xl, Bcl-Xs as preys. pGILDA contains a His3 marker, a CEN/ARS replication origin, and directs the expression of LexA fusion proteins under the control of the GAL1 promoter (Clontech). pJG4-5-Bax DTM has been previously described . A LexA-Bax DTM vector (a gift from P Colas) was digested with EcoRI and XhoI and ligated into EcoRI/XhoIcut pGILDA to generate pGILDA-Bax DTM. All other constructions used in this two hybrid assay have been obtained following the same cloning strategy and expressed fusion proteins devoid of the TM domain. Typically yeasts were grown for 48 h at 308C; in some cases further incubation for 48 h at 48C was carried out to enhance XGal blue coloration.
Cell culture and transfection
Cos-7 cells were grown at 378C, 5% CO 2 in DMEM medium (GIBCO) supplemented with 10% foetal bovine serum and penicillin/streptomycin (Biomedia). Transfections were performed using Fugene 6 reagent (Roche) following the manufacturer's instructions. Brie¯y, for a 6 cm diameter petri dish, 5 mg DNA was added together with Fugene reagent. Fresh culture medium was added 18 h after transfection. Plasmids used for transfection were: pSG5-FLAG-Nrh (this study), pSFFV-BCL-2 (a gift from S Korsmeyer), pSFFV-HA-Bcl-Xs (a gift from G Nunez). In all experiments the total amount of SV40 promoter introduced in Cos-7 cells was maintained constant by cotransfecting corresponding quantities of empty vector.
Cell death assays in Cos-7 cells
Cell death was routinely monitored using standard protocols as described in Cotter and Martin (1996) .
Propidium iodide incorporation and phosphatidylserine exposure Cells were seeded in 35 mm dishes at the density of 10 5 cells. After a 24 h culture at 37.58C, cells were transfected with the various vectors. Serum was 1 day after transfection. Cells were trypsinized 48 h after serum withdrawal and placed in cold PBS for immediate analysis of PI incorporation and Annexin V -FITC labelling (according to Oncogene A human homologue of the anti-apoptotic protein Nr-13 A Aouacheria et al manufacturer's instructions, Roche) using respectively FL2 and FL1 channels of a FACS Calibur TM cyto¯uorometer.
Trypan blue exclusion test Cos-7 were seeded in 24-well plates and cultured in the indicated medium at a density of 5.10 4 cells per well. Cells were grown 48 h at 37.58C and then trypsinized and the number of Trypan blue-positive (dying) and Trypan blue-negative (living) cells was assessed by counting cells on a hemocytometer. Cell viability was estimated by calculating the proportion of cells able to exclude the vital dye Trypan blue. Three independent experiments with 100 ± 200 cells counted for each experimental point were performed. Results are expressed as mean+s.e.m. for a representative experiment. Statistical signi®cance was determined by Student t-test.
Immunocytochemistry
Primary antibodies were Anti-HA (12CA5, Roche), anti-FLAG (M2, Kodak), anti-Bcl-2 (C-2, Santa Cruz) and antinucleoporin (MAB 114). Anti-mouse or anti-rabbit Alexa TM green-labelled secondary were purchased from Molecular Probes. Experiments were essentially carried out following protocols described in Donaldson, 1998. Brie¯y, 2.5.10 4 cells were seeded on 8-well culture chambers (Falcon) and grown for 24 h at 37.58C before being transfected by the appropriate vector. Cells were rinsed twice 24 h later in PBS and ®xed with 4% paraformaldehyde in PBS for 20 min at 48C. Fixed cells were incubated for 10 min with 0.1 M glycine in PBS followed by a 15 min permeabilization step PBS-0.4% Triton X-100. Cells were incubated for 1 h at room temperature in blocking buer consisting of 0.2% gelatin in PBS, and then 1 h with the appropriate primary antibody at room temperature. Cells were washed three times in washing buer (PBS containing 0,2% Tween-20), incubated with Alexa red or green -conjugated anti-rabbit or anti-mouse antibodies (Molecular Probes) in PBS containing 5 mg/ml Hoechst 33258 (Sigma) to visualize nuclei and then examined under a microscope (Zeiss).
Labelling of mitochondria with Mitotracker
TM
To visualize mitochondria, cells were loaded with Mitotracker TM (Mitotracker TM Red CMXRos, Molecular Probes) by incubating in the same medium containing 250 nM Mitotracker TM orange (prepared freshly in DMSO) for 15 min at 37.58C. Care was taken to ensure minimum exposure of cultures to light in all subsequent manipulations. After four washes with PBS, cells were ®xed with 4% paraformaldehyde in PBS for 20 min at 48C and incubated 30 min with 5 mg/ml Hoechst 33258 in PBS to visualize nuclei. Representative ®elds of cells were photographed under¯uorescence microscopy (Zeiss microscope) to visualize bisbenzimide and Mitotracker staining (Kodak ®lm, ASA 200).
